PERL Continuous Glucose Monitoring (CGM) Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Alessandro Doria, MD PhD MPH
Joslin Diabetes Center
Principal Investigator - Irl Hirsch, MD
University of Washington
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Unversity of Calgary
Calgary, Alberta, Canada
- University of Alberta
Edmonton, Alberta, Canada
- Bc Diabetes
Vancouver, British Columbia, Canada
- University of Toronto
Toronto, Ontario, Canada
- Barbara Davis Center / University of Colorado Denver
Aurora, Colorado, United States
- Emory University - Grady Memorial Hospital
Atlanta, Georgia, United States
- Northwestern University Feinberg School of Medicine
Chicago, Illinois, United States
- Joslin Diabetes Center
Boston, Massachusetts, United States
- Brehm Center for Diabetes Research / University of Michigan
Ann Arbor, Michigan, United States
- Henry Ford Health System
Detroit, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Icahn School of Medicine at Mount Sinai
New York, New York, United States
- Suny Upstate Medical University
Syracuse, New York, United States
- Albert Einstein College of Medicine / Montefiore Medical Center
The Bronx, New York, United States
- Ut Southwestern Dallas
Dallas, Texas, United States
- University of Washington
Seattle, Washington, United States
- Virginia Mason Medical Center
Seattle, Washington, United States
- Providence Sacred Heart Medical Center
Spokane, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Oct 2017
- Primary completion
- 31 Aug 2019
- Completion
- 31 Dec 2021
- Last update posted
- 29 Mar 2022
- Registered enrollment
- 175
- Registry id
- NCT03334318
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.